From the U.S. Chamber of Commerce

The U.S. Food and Drug Administration (FDA) recently granted emergency use authorization for COVID-19 vaccines developed by Pfizer and Moderna. As states begin to prioritize, allocate, and distribute the first doses, the U.S. Chamber has created a new COVID-19 Vaccines FAQ one-pager to answer the common questions being asked by Americans—and especially business leaders.

Click here to view the one-pager with accurate and current information about the vaccine allocation process, expected timelines, and what it all means for the road to recovery.